ToxSci Advance Access originally published online on June 30, 2004
Toxicological Sciences 2004 81(2):502-511; doi:10.1093/toxsci/kfh206
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences vol. 81 no. 2 © Society of Toxicology 2004; all rights reserved.
Subchronic Toxicity of Ethylene Glycol in Wistar and F-344 Rats Related to Metabolism and Clearance of Metabolites



* ToxWorks, Bridgeton, New Jersey;
Pacific Northwest National Laboratory, Richland, Washington;
Tairua, 2853, New Zealand;
WIL Research Laboratories, Inc., Ashland, Ohio; ¶ Louisiana State University Health Sciences Center, Shreveport, Louisiana; || American Chemistry Council, Ethylene Oxide/Ethylene Glycol CHEMSTAR Panel, Arlington, Virginia
Received April 22, 2004; accepted June 24, 2004
Ethylene glycol (CAS RN 107211) can cause kidney toxicity via the formation of calcium oxalate crystals in a variety of species, including humans. Numerous repeated dose studies conducted in rats have indicated that male rats are more susceptible than female rats. Furthermore, subchronic and chronic studies using different dietary exposure regimens have indicated that male Wistar rats may be more sensitive to renal toxicity than male Fischer-344 (F-344) rats. This study was conducted to compare the toxicity of ethylene glycol in the two strains of rats under identical exposure conditions and to evaluate the potential contribution of toxicokinetic differences to strain sensitivity. Ethylene glycol was mixed in the diet at concentrations to deliver constant target dosage levels of 0, 50, 150, 500, or 1000 mg/kg/day for 16 weeks to groups of 10 male Wistar and 10 male F-344 rats based on weekly group mean body weights and feed consumption. Kidneys were examined histologically for calcium oxalate crystals and pathology. Samples of blood, urine, and kidneys from satellite animals exposed to 0, 150, 500, or 1000 mg/kg/day for 1 or 16 weeks were analyzed for ethylene glycol, glycolic acid, and oxalic acid. Treatment of Wistar rats at 1000 mg/kg/day resulted in the death of two rats; in addition, at 500 and 1000 mg/kg/day, group mean body weights were decreased compared to control throughout the 16 weeks. In F-344 rats exposed at 1000 mg/kg/day and in Wistar rats receiving 500 and 1000 mg/kg/day, there were lower urine specific gravities, higher urine volumes, and increased absolute and relative kidney weights. In both strains of rats treated at 500 and 1000 mg/kg/day, some or all treated animals had increased calcium oxalate crystals in the kidney tubules and crystal nephropathy. The effect was more severe in Wistar rats than in F-344 rats. Accumulation of oxalic acid in the kidneys of both strains of rats was consistent with the dose-dependent and strain-dependent toxicity. As the nephrotoxicity progressed over the 16 weeks, the clearance of ethylene glycol and its metabolites decreased, exacerbating the toxicity. Benchmark dose analysis indicated a BMDL05 for kidney toxicity in Wistar rats of 71.5 mg/kg/day; nearly fourfold lower than in F-344 rats (285 mg/kg/day). This study confirms that the Wistar rat is more sensitive to ethylene glycolinduced renal toxicity than the F-344 rat and indicates that metabolism or clearance plays a role in the strain differences.
Key Words: ethylene glycol; nephropathy; metabolism; oxalate.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Li and K. E. McMartin Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1080 - F1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Corley and K. E. McMartin Incorporation of Therapeutic Interventions in Physiologically Based Pharmacokinetic Modeling of Human Clinical Case Reports of Accidental or Intentional Overdosing with Ethylene Glycol Toxicol. Sci., May 1, 2005; 85(1): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Corley, M. J. Bartels, E. W. Carney, K. K. Weitz, J. J. Soelberg, R. A. Gies, and K. D. Thrall Development of a Physiologically Based Pharmacokinetic Model for Ethylene Glycol and Its Metabolite, Glycolic Acid, in Rats and Humans Toxicol. Sci., May 1, 2005; 85(1): 476 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. McMartin and K. B. Wallace Calcium Oxalate Monohydrate, a Metabolite of Ethylene Glycol, Is Toxic for Rat Renal Mitochondrial Function Toxicol. Sci., March 1, 2005; 84(1): 195 - 200. [Abstract] [Full Text] [PDF] |
||||

